Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide

Arthritis Rheum. 1994 Dec;37(12):1784-94. doi: 10.1002/art.1780371212.

Abstract

Objective: To investigate the effect of an intensified treatment protocol synchronizing plasmapheresis with subsequent pulse cyclophosphamide for severe systemic lupus erythematosus (SLE).

Methods: A protocol of plasmapheresis (3 x 60 ml/kg) and subsequent high-dose pulse cyclophosphamide (36 mg/kg) followed by 6 months of peroral immunosuppression was used to treat 14 patients with severe SLE.

Results: Rapid improvement was achieved in all patients. Immunosuppressants, including corticosteroids, were withdrawn at month 6 in 12 patients. Eight patients continued without treatment for a mean observation period of 5.6 years (46-91 months).

Conclusion: The results demonstrate that treatment-free clinical remission can be achieved in some patients with severe SLE.

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Amenorrhea / physiopathology
  • Complement C4 / analysis
  • Complement C4 / deficiency
  • Creatinine / blood
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / therapeutic use*
  • Dose-Response Relationship, Drug
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoglobulins / metabolism
  • Kinetics
  • Leukocyte Count
  • Leukopenia / etiology
  • Lupus Erythematosus, Systemic / complications
  • Lupus Erythematosus, Systemic / therapy*
  • Middle Aged
  • Plasmapheresis*
  • Pregnancy
  • Pregnancy Complications / physiopathology
  • Pulsatile Flow
  • Time Factors

Substances

  • Complement C4
  • Immunoglobulins
  • Cyclophosphamide
  • Creatinine